Your browser doesn't support javascript.
loading
Value of the loss of heterozygosity to BRCA1 variant classification.
Santana Dos Santos, Elizabeth; Spurdle, Amanda B; Carraro, Dirce M; Briaux, Adrien; Southey, Melissa; Torrezan, Giovana; Petitalot, Ambre; Leman, Raphael; Lafitte, Philippe; Meseure, Didier; Driouch, Keltouma; Side, Lucy; Brewer, Carole; Beck, Sarah; Melville, Athalie; Callaway, Alison; Revillion, Françoise; Folgueira, Maria A A Koike; Parsons, Michael T; Thorne, Heather; Vincent-Salomon, Anne; Stoppa-Lyonnet, Dominique; Bieche, Ivan; Caputo, Sandrine M; Rouleau, Etienne.
Afiliação
  • Santana Dos Santos E; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France. elizabeth.santanadossantos@gmail.com.
  • Spurdle AB; Department of Medical Biology and Pathology, Gustave Roussy, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France. elizabeth.santanadossantos@gmail.com.
  • Carraro DM; Department of Clinical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil. elizabeth.santanadossantos@gmail.com.
  • Briaux A; Department of Oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil. elizabeth.santanadossantos@gmail.com.
  • Southey M; Centro de Oncologia Hospital Sírio Libanês-São Paulo, São Paulo, Brazil. elizabeth.santanadossantos@gmail.com.
  • Torrezan G; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Petitalot A; Molecular Biology and Genomics Group, A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Leman R; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, PSL Research University, Sao Paulo, Brazil.
  • Lafitte P; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.
  • Meseure D; Laboratory of Clinical Biology and Oncology, Centre François Baclesse, Inserm U1245 Genomics and Personalized Medicine in Cancer and Neurological Disorders, Normandy University, Caen, France.
  • Driouch K; Department of Pathology, The University of Melbourne, 3010, Victoria, Australia.
  • Side L; Molecular Biology and Genomics Group, A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Brewer C; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, PSL Research University, Sao Paulo, Brazil.
  • Beck S; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.
  • Melville A; Research University, PSL, Paris, France.
  • Callaway A; Laboratory of Clinical Biology and Oncology, Centre François Baclesse, Inserm U1245 Genomics and Personalized Medicine in Cancer and Neurological Disorders, Normandy University, Caen, France.
  • Revillion F; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.
  • Folgueira MAAK; Research University, PSL, Paris, France.
  • Thorne H; Department of Pathology, Institut Curie, 26 rue d'Ulm, Paris, France.
  • Vincent-Salomon A; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.
  • Stoppa-Lyonnet D; Research University, PSL, Paris, France.
  • Bieche I; Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Caputo SM; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, UK.
  • Rouleau E; Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
NPJ Breast Cancer ; 8(1): 9, 2022 Jan 17.
Article em En | MEDLINE | ID: mdl-35039532
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article